Skip to main content

Advertisement

Log in

New insights into synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

In 1987, synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome was proposed as an umbrella term for a group of diseases with similar musculoskeletal manifestations, in particular hyperostosis of anterior chest wall, synovitis, and multifocal aseptic osteomyelitis, observed in association with dermatologic conditions such as palmoplantar pustulosis, severe acne, and hidradenitis suppurativa. Despite recent advances in our understanding of the epidemiologic, pathophysiologic, and immunogenetic mechanisms involved in SAPHO syndrome, etiopathogenesis remains poorly understood. Propionibacterium acnes, the microorganism associated with acne, has been recovered on bone biopsy in some patients, but the possible pathogenetic role of an infectious agent in a genetically predisposed individual, resulting in exaggerated inflammatory response as “reactive osteitis,“ is a largely unproven hypothesis. The newly available whole-body MRI will assist early diagnosis by detecting multifocal osteitis lesions, some of them asymptomatic, in axial (anterior chest wall, spine, and jaws) and nonaxial sites. Moreover, outcomes are vastly improved by treatment with bisphosphonates and tumor necrosis factor-α antagonists.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Chamot AM, Benhamou CL, Kahn MF, et al.: Acne-pustulosis-hyperostosis-osteitis syndrome: results of a national survey-85 cases [in French]. Rev Rhum Mal Osteoartic 1987, 54:187–196.

    PubMed  CAS  Google Scholar 

  2. Benhamou CL, Chamot AM, Kahn MF: Synovitis-acnepustulosis hyperostosis-osteomyelitis syndrome (SAPHO). A new syndrome among the spondyloarthropathies? Clin Exp Rheumatol 1988, 6:109–112.

    PubMed  CAS  Google Scholar 

  3. Kahn MF, Khan MA: The SAPHO syndrome. Baillieres Clin Rheumatol 1994, 8:333–362.

    Article  PubMed  CAS  Google Scholar 

  4. Bjorksten B, Gustavson KH, Eriksson B, et al.: Chronic recurrent multifocal osteomyelitis and pustulosis palmoplantaris. J Pediatr 1978, 93:227–231.

    Article  PubMed  CAS  Google Scholar 

  5. Colina M, Govoni M, Orzincolo C, Trotta F: Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a single center study of a cohort of 71 subjects. Arthritis Rheum 2009, 61:813–821.

    Article  PubMed  Google Scholar 

  6. Takigawa T, Tanaka M, Nakanishi K, et al.: SAPHO syndrome associated spondylitis. Eur Spine J 2008, 17:1391–1397.

    Article  PubMed  Google Scholar 

  7. Hayem G, Bouchaud-Chabot A, Benali K, et al.: SAPHO syndrome: a long-term follow-up study of 120 cases. Semin Arthritis Rheum 1999, 29:159–171.

    Article  PubMed  CAS  Google Scholar 

  8. Govoni M, Colina M, Massara A, Trotta F: SAPHO syndrome and infections. Autoimmun Rev 2009, 8:256–259.

    Article  PubMed  CAS  Google Scholar 

  9. Colina M, Lo Monaco A, Khodeir M, Trotta F: Propionibacterium acnes and SAPHO syndrome: a case report and literature review. Clin Exp Rheumatol 2007, 25:457–460.

    PubMed  CAS  Google Scholar 

  10. Delyle LG, Vittecoq O, Bourdel A, et al.: Chronic destructive oligoarthritis associated with Propionibacterium acnes in a female patient with acne vulgaris: septic-reactive arthritis? Arthritis Rheum 2000, 43:2843–2847.

    Article  PubMed  CAS  Google Scholar 

  11. Kotilainen P, Merilahti-Palo R, Lehtonen OP, et al.: Propionibacterium acnes isolated from sternal osteitis in a patient with SAPHO syndrome. J Rheumatol 1996, 23:1302–1304.

    PubMed  CAS  Google Scholar 

  12. Queiro R, Moreno P, Sarasqueta C, et al.: Synovitis-acnepustulosis-hyperostosis-osteitis syndrome and psoriatic arthritis exhibit a different immunogenetic profile. Clin Exp Rheumatol 2008, 26:125–128.

    PubMed  CAS  Google Scholar 

  13. Ferguson PJ, Bing X, Vasef MA, et al.: A missense mutation in pstpip2 is associated with the murine autoinflammatory disorder chronic multifocal osteomyelitis. Bone 2006, 38:41–47.

    Article  PubMed  CAS  Google Scholar 

  14. Golla A, Jansson A, Ramser J, et al.: Chronic recurrent multifocal osteomyelitis (CRMO): evidence for a susceptibility gene located on chromosome 18q21.3–18q22. Eur J Hum Genet 2002, 10:217–221.

    Article  PubMed  Google Scholar 

  15. Hayem G: Valuable lessons from SAPHO syndrome. Joint Bone Spine 2007, 74:123–126.

    Article  PubMed  Google Scholar 

  16. Hurtado-Nedelec M, Chollet-Martin S, Nicaise-Roland P, et al.: Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome. Rheumatology (Oxford) 2008, 47:1160–1167.

    Article  CAS  Google Scholar 

  17. Ferguson PJ, Lokuta MA, El-Shanti HI, et al.: Neutrophil dysfunction in a family with a SAPHO syndrome-like phenotype. Arthritis Rheum 2008, 58:3264–3269.

    Article  PubMed  CAS  Google Scholar 

  18. Kahn MF, Bouvier M, Palazzo E, et al.: Sternoclavicular pustulotic osteitis (SAPHO): 20-year interval between skin and bone lesions. J Rheumatol 1991, 18:1104–1108.

    PubMed  CAS  Google Scholar 

  19. Earwaker JW, Cotten A: SAPHO: syndrome or concept? Imaging findings. Skeletal Radiol 2003, 32:311–327.

    PubMed  CAS  Google Scholar 

  20. Cabay JE, Marcelis S, Dondelinger RF: Inflammatory spondylodiskitis as a unique radiological manifestation of the SAPHO syndrome [in French]. J Radiol 1998, 79:337–340.

    PubMed  CAS  Google Scholar 

  21. Boutin RD, Resnick D: The SAPHO syndrome: an evolving concept for unifying several idiopathic disorders of bone and skin. AJR Am J Roentgenol 1988, 170:585–591.

    Google Scholar 

  22. Van Doornum S, Barraclough D, McColl G, Wicks I: SAPHO: rare or just not recognized? Semin Arthritis Rheum 2000, 30:70–77.

    Article  PubMed  Google Scholar 

  23. Karadag-Saygi E, Gunduz OH, Gumrukcu G, Akyuz G: SAPHO syndrome: misdiagnosed and operated. Acta Reumatol Port 2008, 33:460–463.

    PubMed  Google Scholar 

  24. Freyschmidt J, Sternberg A: The bull’s head sign: scintigraphy pattern of sternoclavicular hyperostosis and pustulotic arthrosclerosis. Eur Radiol 1998, 8:807–812.

    Article  PubMed  CAS  Google Scholar 

  25. Laredo JD, Vuillemin-Bodaghi V, Boutry N, et al.: SAPHO syndrome: MR appearance of vertebral involvement. Radiology 2007, 242:825–831.

    Article  PubMed  Google Scholar 

  26. Romanus R, Yden S: Destructive and ossifying spondylitic changes in rheumatoid ankylosing spondylitis (pelvospondylitis ossificans). Acta Orthop Scand 1952, 22:88–99.

    Article  PubMed  CAS  Google Scholar 

  27. Jevtic V, Kos-Golja M, Rozman B, McCall I: Marginal erosive discovertebral “Romanus” lesions in ankylosing spondylitis demonstrated by contrast enhanced Gd-DTPA magnetic resonance imaging. Skeletal Radiol 2000, 29:27–33.

    Article  PubMed  CAS  Google Scholar 

  28. Weber U, Hodler J, Jurik AG, et al.: Assessment of active spinal inflammatory changes in patients with axial spondyloarthritis: validation of whole body MRI against conventional MRI. Ann Rheum Dis 2009, May 7 (Epub ahead of print).

  29. Weber U, Pfirrmann CWA, Khan MA: Ankylosing spondylitis: update on imaging and therapy. Intl J Adv Rheumatol 2007, 5:2–7.

    Google Scholar 

  30. Olivieri I, Padula A, Palazzi C: Pharmacological management of SAPHO syndrome. Expert Opin Investig Drugs 2006, 15:1229–1233.

    Article  PubMed  CAS  Google Scholar 

  31. Kalke S, Perera SD, Patel ND, et al.: The sternoclavicular syndrome: experience from a district general hospital and results of a national postal survey. Rheumatology (Oxford) 2001, 40:170–177.

    Article  CAS  Google Scholar 

  32. Pennanen N, Lapinjoki S, Urtti A, Monkkonen J: Effect of liposomal and free bisphosphonates on the IL-1a, IL-6, and TNFα secretion from RAW264 cells in vitro. Pharm Res 1995, 12:916–22.

    Article  PubMed  CAS  Google Scholar 

  33. Maksymowych WP: Bisphosphonates for arthritis—a confusing rationale. J Rheum 2003, 30:430–434.

    PubMed  Google Scholar 

  34. Colina M, La Corte R, Trotta F: Sustained remission of SAPHO syndrome with pamidronate: a follow-up of fourteen cases and a review of the literature. Clin Exp Rheumatol 2009, 27:112–125.

    PubMed  CAS  Google Scholar 

  35. Amital H, Applbaum YH, Aamar S, et al.: SAPHO syndrome treated with pamidronate: an open-label study of 10 patients. Rheumatology (Oxford) 2004, 43:658–661.

    Article  CAS  Google Scholar 

  36. Marshall H, Bromilow J, Thomas AL, Arden NK: Pamidronate: a novel treatment for the SAPHO syndrome? Rheumatology 2002, 41:231–233.

    Article  PubMed  CAS  Google Scholar 

  37. Guignard S, Job-Deslandre C, Sayag-Boukris V, Kahan A: Pamidronate treatment in SAPHO syndrome. Joint Bone Spine 2002, 69:392–396.

    Article  PubMed  CAS  Google Scholar 

  38. Courtney PA, Hosking DJ, Fairbairn KJ, Deighton CM: Treatment of SAPHO with pamidronate. Rheumatology 2002, 41:1196–1198.

    Article  PubMed  CAS  Google Scholar 

  39. Kerrison C, Davidson JE, Cleary AG, Beresford MW: Pamidronate in the treatment of childhood SAPHO syndrome. Rheumatology 2004, 43:1246–1251.

    Article  PubMed  CAS  Google Scholar 

  40. Kopterides P, Pikazis D, Koufos C: Successful treatment of SAPHO syndrome with zoledronic acid. Arthritis Rheum 2004, 50:2970–2973.

    Article  PubMed  Google Scholar 

  41. Just A, Adams S, Brinkmeier T, et al.: Successful treatment of primary chronic osteomyelitis in SAPHO syndrome with bisphosphonates [in German]. J Dtsch Dermatol Ges 2008, 6:657–660.

    Article  PubMed  Google Scholar 

  42. Wagner AD, Andresen J, Jendro MC, et al.: Sustained response to tumor necrosis factor a-blocking agents in two patients with SAPHO syndrome. Arthritis Rheum 2002, 46:1965–1968.

    Article  PubMed  Google Scholar 

  43. Olivieri I, Padula A, Ciancio G, et al.: Successful treatment of SAPHO syndrome with infliximab: report of two cases. Ann Rheum Dis 2002, 61:375–376.

    Article  PubMed  CAS  Google Scholar 

  44. Iqbal M, Kolodney MS: Acne fulminans with synovitisacne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome treated with infliximab. J Am Acad Dermatol 2005, 52:S118–S120.

    Article  PubMed  Google Scholar 

  45. Deutschmann A, Mache CJ, Bodo K, et al.: Successful treatment of chronic recurrent multifocal osteomyelitis with tumor necrosis factor-a blockage. Pediatrics 2005, 116:1231–1233.

    Article  PubMed  Google Scholar 

  46. Massara A, Cavazzini PL, Trotta F: In SAPHO syndrome anti-TNF-a therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations. Rheumatology 2006, 45:730–733.

    Article  PubMed  CAS  Google Scholar 

  47. Schilling F, Wagner AD: Azithromycin: an anti-inflammatory effect in chronic recurrent multifocal osteomyelitis? A preliminary report [in German]. Z Rheumatol 2000, 59:352–353.

    Article  CAS  PubMed  Google Scholar 

  48. Ballara SC, Siraj QH, Maini RN, Venables PJ: Sustained response to doxycycline therapy in two patients with SAPHO syndrome. Arthritis Rheum 1999, 42:819–821.

    Article  PubMed  CAS  Google Scholar 

  49. Rozin AP, Nahir AM: Is SAPHO syndrome a target for antibiotic therapy? Clin Rheumatol 2007, 26:817–820.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Muhammad A. Khan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Magrey, M., Khan, M.A. New insights into synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome. Curr Rheumatol Rep 11, 329–333 (2009). https://doi.org/10.1007/s11926-009-0047-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-009-0047-8

Keywords

Navigation